Fighting For Dogs: A Drug Company's Push To End Animal Testing
A major push is underway to end lab testing on dogs by pharmaceutical companies.
On this bonus episode of The Exam Room™, "The Weight Loss Champion" Chuck Carroll is joined by Elizabeth Baker, pharmaceutical policy program director for the Physicians Committee, who shares the incredible story of Vanda Pharmaceuticals. The biopharmaceutical company is working to end animal testing even at the expense of their bottom line.
As you'll hear, Vanda was ordered by the FDA to test a potential new drug for a stomach disorder on dogs. However, the company's researchers concluded that the study would not be useful and cause unnecessary animal suffering. Vanda then asked FDA not to require the dog study, which would have taken place after the drug was already being tested in humans.
But the FDA pushed back and barred Vanda from continuing with any further trials. Now, Vanda is fighting back!
Baker also discusses the modern non-animal testing methods that are faster and more cost-effective in bringing drugs to market.
--- ---
Donate to PCRM
--- ---
Chuck Carroll
Twitter: @ChuckCarrollWLC
IG: @ChuckCarrollWLC
--- ---
Physicians Committee
Twitter: @PCRM
--- ---
Share the Show
Please subscribe and give the show a 5-star rating on Apple Podcasts, Spotify or many other podcast providers. Don't forget to share it with a friend for inspiration!
Available Results
Generated results are saved to your library for reuse and search.
Choose Template
Pick the result you want. You can review provider and model before generating.
A concise first-pass summary for understanding the episode quickly.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Explicit actions, next steps, habits, recommendations, and things to avoid.
Repeatable methods, frameworks, mental models, processes, and systems.
A dedicated inventory of concrete resources named in the episode.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Explicit actions, next steps, habits, recommendations, and things to avoid.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.
A concise first-pass summary for understanding the episode quickly.
A detailed readable summary organized by chapter or topic.
A navigable map of subjects, topic flow, and suggested chapters.
A comprehensive, source-grounded extraction of the reusable knowledge in an episode.
Reusable atomic knowledge units extracted from the episode.
A comprehensive extraction focused on health practices, protocols, claims, and safety caveats.
A comprehensive extraction focused on opportunities, strategy, markets, and company building.
Scientific findings, mechanisms, studies, hypotheses, and the limits of the evidence discussed.
Technologies, AI models, technical methods, capabilities, limitations, and adoption implications.
Investment theses, assets, catalysts, valuation reasoning, time horizons, and risks.
Chronologies, actors, causes, consequences, turning points, and competing historical interpretations.
Policies, proposals, stakeholders, arguments, implementation constraints, and predicted effects.
Career paths, skills, hiring signals, workplace decisions, transitions, and limitations of the advice.
Behavioral mechanisms, biases, motivation, habits, emotions, interventions, and evidence limitations.
Economic mechanisms, incentives, indicators, market structure, forecasts, and uncertainty.
Leadership principles, team systems, organizational design, culture, feedback, and failure modes.
Audience, positioning, messaging, acquisition, retention, experiments, metrics, and failed approaches.
Teaching methods, learning strategies, practice, feedback, assessment, and effectiveness evidence.
Theses, premises, arguments, objections, values, thought experiments, and unresolved questions.
Communication patterns, conflict, boundaries, expectations, repair methods, and contextual limitations.
Books, papers, authors, courses, and other learning resources mentioned in the episode.
Repeatable methods, frameworks, mental models, processes, and systems.
Explicit actions, next steps, habits, recommendations, and things to avoid.
Memorable statements and important claims with attribution and source context.
A dedicated inventory of concrete resources named in the episode.
A dedicated analysis of warnings, limitations, trade-offs, weak evidence, and uncertainty.